Skip to main content

Hatteras-backed Durham startup aims to treat 'undruggable' cancer targets

The startup is developing its own internal pipeline focused on therapeutics for cancer targets considered "undruggable." And it just raised millions to support the effort.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.